ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT03300505 · TERMINATED
Trial details
- NCT number
- NCT03300505
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2023-01-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.